• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy & Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Press Releases
    • Media Requests
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

COVID-19

February 5, 2021

Selected References:

  • Allotey J, et al. 2020. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370:m3320.
  • American College of Obstetricians and Gynecologists. 2020. Practice Advisory: Novel Coronavirus 2019 (COVID-19). Available at URL: https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Novel-Coronavirus2019
  • American Society of Hematology. 2021. COVID-19 and VTE/anticoagulation: frequently asked questions. Available at URL: https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
  • Blumberg, DA, et al. 2020. Vertical transmission of SARS-CoV-2: what is the optimal definition? Am J Perinatol 37(8):769-772.
  • Centers for Disease Control and Prevention. 2020. Coronavirus (COVID-19). Available at URL: https://www.cdc.gov/coronavirus/2019-nCoV/index.html
  • Chambers, et al. 2020. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA 324(13):1347-1348.
  • Chen H, et al. 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395(10226):809-815.
  • Delahoy MJ, et al. 2020. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1347–1354.
  • Ellington S, et al. 2020. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69:769–775.
  • Gulersen M, et al. 2020. Clinical implications of SARS-CoV-2 infection in the viable preterm period. Am J Perinatol 37(11): 1077-1083.
  • Holtmann N, et al. 2020. Assessment of SARS-CoV-2 in human semen – a cohort study. Fertility and Sterility 114 (2):233-238.
  • Jering K, et al. 2021. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. Published online Jan 15, 2021. doi: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2775396
  • Khoury R, et al. 2020. MD Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers.  Obstetrics & Gynecology 136(2):273-282.
  • Li Y, et al. 2020. Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis 26(6):1335-1336.
  • Salvatore CM, et al. 2020. Neonatal management and outcomes during the COIVD-19 pandemic: an observation cohort study. Lancet Child & Adol Health 4(10):721-727.
  • Shah PS, et al. 2020. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates. Acta Obstet Gynecol Scand 99: 565 68.
  • Vivanti AJ, et al. 2020. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 11, 3572.
  • Woodworth KR, et al. 2020. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep 69(44);1635–1640.
  • Zambrano LD, et al. 2020. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 69:769–75.
  • Zeng L, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 174(7):722-725.
  • Zhu H, et al. 2020. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 9(1):51-60.

 

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whopping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2021 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^